Â¥
47.41
Sep 30
Business Description
BGI Genomics Co Ltd
ISIN : CNE100003449
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.21 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 4.87 | |||||
Interest Coverage | 2.82 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.42 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.5 | |||||
3-Year EBITDA Growth Rate | -39.6 | |||||
3-Year EPS without NRI Growth Rate | -64.7 | |||||
3-Year Book Growth Rate | 17.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 97.26 | |||||
9-Day RSI | 92.03 | |||||
14-Day RSI | 86.06 | |||||
6-1 Month Momentum % | -11.65 | |||||
12-1 Month Momentum % | -30.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.74 | |||||
Quick Ratio | 2.52 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 107.6 | |||||
Days Sales Outstanding | 138.31 | |||||
Days Payable | 155.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.21 | |||||
Dividend Payout Ratio | 0.21 | |||||
3-Year Dividend Growth Rate | 114.7 | |||||
Forward Dividend Yield % | 0.21 | |||||
5-Year Yield-on-Cost % | 0.74 | |||||
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | -1.18 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.68 | |||||
Operating Margin % | 5.81 | |||||
Net Margin % | 1.48 | |||||
FCF Margin % | -14.07 | |||||
ROE % | 0.62 | |||||
ROA % | 0.45 | |||||
ROIC % | 2.83 | |||||
3-Year ROIIC % | -82.04 | |||||
ROC (Joel Greenblatt) % | 5.14 | |||||
ROCE % | 1.57 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 322.52 | |||||
Forward PE Ratio | 112.88 | |||||
PE Ratio without NRI | 100.44 | |||||
Shiller PE Ratio | 29.45 | |||||
PEG Ratio | 13.57 | |||||
PS Ratio | 4.75 | |||||
PB Ratio | 1.96 | |||||
Price-to-Tangible-Book | 2.1 | |||||
Price-to-Operating-Cash-Flow | 59.87 | |||||
EV-to-EBIT | 77.21 | |||||
EV-to-EBITDA | 77.21 | |||||
EV-to-Revenue | 3.04 | |||||
EV-to-FCF | -21.62 | |||||
Price-to-Projected-FCF | 1.69 | |||||
Price-to-Graham-Number | 3.06 | |||||
Price-to-Net-Current-Asset-Value | 4.55 | |||||
Price-to-Net-Cash | 12.31 | |||||
Earnings Yield (Greenblatt) % | 1.3 | |||||
FCF Yield % | -2.96 | |||||
Forward Rate of Return (Yacktman) % | -17.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BGI Genomics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 4,149.256 | ||
EPS (TTM) (Â¥) | 0.147 | ||
Beta | 1.49 | ||
Volatility % | 47.51 | ||
14-Day RSI | 86.06 | ||
14-Day ATR (Â¥) | 1.676689 | ||
20-Day SMA (Â¥) | 36.1 | ||
12-1 Month Momentum % | -30.69 | ||
52-Week Range (Â¥) | 33 - 55.58 | ||
Shares Outstanding (Mil) | 415.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BGI Genomics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BGI Genomics Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
BGI Genomics Co Ltd Frequently Asked Questions
What is BGI Genomics Co Ltd(SZSE:300676)'s stock price today?
When is next earnings date of BGI Genomics Co Ltd(SZSE:300676)?
Does BGI Genomics Co Ltd(SZSE:300676) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |